These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37655363)

  • 41. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of Mickey Mouse Ears' Sign in Progressive Supranuclear Palsy.
    Chow TK; Ma KM
    Clin Nucl Med; 2024 Jun; 49(6):551-553. PubMed ID: 38598736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synaptic Loss in Primary Tauopathies Revealed by [
    Holland N; Jones PS; Savulich G; Wiggins JK; Hong YT; Fryer TD; Manavaki R; Sephton SM; Boros I; Malpetti M; Hezemans FH; Aigbirhio FI; Coles JP; O'Brien J; Rowe JB
    Mov Disord; 2020 Oct; 35(10):1834-1842. PubMed ID: 32652635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal Synaptic Loss in Primary Tauopathies: An In Vivo [
    Holland N; Jones PS; Savulich G; Naessens M; Malpetti M; Whiteside DJ; Street D; Swann P; Hong YT; Fryer TD; Rittman T; Mulroy E; Aigbirhio FI; Bhatia KP; O'Brien JT; Rowe JB
    Mov Disord; 2023 Jul; 38(7):1316-1326. PubMed ID: 37171832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Utility of
    Li L; Liu FT; Li M; Lu JY; Sun YM; Liang X; Bao W; Chen QS; Li XY; Zhou XY; Guan Y; Wu JJ; Yen TC; Jang MK; Luo JF; Wang J; Zuo C;
    Mov Disord; 2021 Oct; 36(10):2314-2323. PubMed ID: 34089275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Liu FT; Lu JY; Li XY; Jiao FY; Chen MJ; Yao RX; Liang XN; Ju ZZ; Ge JJ; Li G; Shen B; Wu P; Song J; Li J; Sun YM; Wu JJ; Yen TC; Luo JF; Zhao QH; Zuo C; Wang J;
    Mov Disord; 2023 Apr; 38(4):579-588. PubMed ID: 36750757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo binding of a tau imaging probe, [
    Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M
    Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Seniaray N; Verma R; Ranjan R; Belho E; Mahajan H
    Ann Indian Acad Neurol; 2022; 25(5):880-889. PubMed ID: 36561021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
    Amtage F; Hellwig S; Kreft A; Spehl T; Glauche V; Winkler C; Rijntjes M; Hellwig B; Weiller C; Weber WA; Tüscher O; Meyer PT
    Clin Nucl Med; 2014 Apr; 39(4):319-25. PubMed ID: 24566396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
    J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of short imaging protocols for [
    Song M; Scheifele M; Barthel H; van Eimeren T; Beyer L; Marek K; Eckenweber F; Palleis C; Kaiser L; Finze A; Kern M; Nitschmann A; Biechele G; Katzdobler S; Bischof G; Hammes J; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Stephens AW; Rauchmann BS; Perneczky R; Levin J; Classen J; Höglinger GU; Bartenstein P; Boening G; Ziegler S; Villemagne V; Drzezga A; Seibyl J; Sabri O; Brendel M;
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3872-3885. PubMed ID: 34021393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.
    Campagnolo M; Weis L; Fogliano C; Cianci V; Garon M; Fiorenzato E; Carecchio M; Ferreri F; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2023 Feb; 130(2):97-109. PubMed ID: 36701008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
    Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
    Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
    Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.